|
| Status |
Public on Feb 27, 2023 |
| Title |
CstF64 iCLIP-seq in control and U1 AMO-treated HeLa cells |
| Organism |
Homo sapiens |
| Experiment type |
Other
|
| Summary |
To understand the effect of U1 AMO treatment on CstF64 binding profile , we carried out CstF64 iCLIP-seq experiments in HeLa cells treated with either control or U1 AMO.
|
| |
|
| Overall design |
Control and U1 AMO were transfected into HeLa cells,after 12 hour. CstF64 iCLIP-seq(s) were carried out using the standard iCLIP-seq protocol (König J et al. 2010)
|
| |
|
| Contributor(s) |
Deng Y, Ran Y, Shi J, Yao C |
| Citation(s) |
37224962 |
| |
| Submission date |
Jan 02, 2022 |
| Last update date |
May 29, 2023 |
| Contact name |
chengguo yao |
| E-mail(s) |
yaochguo@mail.sysu.edu.cn
|
| Organization name |
sysu
|
| Department |
school of medicine
|
| Street address |
No. 74 zhongshan 2rd road
|
| City |
guangzhou |
| ZIP/Postal code |
510080 |
| Country |
China |
| |
|
| Platforms (1) |
| GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
| Samples (4)
|
|
| This SubSeries is part of SuperSeries: |
| GSE192943 |
The U1 antisense morpholino oligonucleotide (AMO) disrupts U1 snRNP structure to promote intronic PCPA modification of pre-mRNAs |
|
| Relations |
| BioProject |
PRJNA793685 |
Less...
More...